Cyclin-dependent kinases (CDKs) play crucial roles in promoting DNA replication and preventing rereplication in eukaryotic cells [1] [2] [3] [4] . In budding yeast, CDKs promote DNA replication by phosphorylating two proteins, Sld2 and Sld3, which generates binding sites for pairs of BRCT repeats (breast cancer gene 1 [BRCA1] C terminal repeats) in the Dpb11 protein [5, 6] . The Sld3-Dpb11-Sld2 complex generated by CDK phosphorylation is required for the assembly and activation of the Cdc45-Mcm2-7-GINS (CMG) replicative helicase. In response to DNA replication stress, the interaction between Sld3 and Dpb11 is blocked by the checkpoint kinase Rad53 [7] , which prevents late origin firing [7, 8] . Here we show that the two key CDK sites in Sld3 are conserved in the human Sld3-related protein Treslin/ticrr and are essential for DNA replication. Moreover, phosphorylation of these two sites mediates interaction with the orthologous pair of BRCT repeats in the human Dpb11 ortholog, TopBP1. Finally, we show that DNA replication stress prevents the interaction between Treslin/ticrr and TopBP1 via the Chk1 checkpoint kinase. Our results indicate that Treslin/ticrr is a genuine ortholog of Sld3 and that the Sld3-Dpb11 interaction has remained a critical nexus of S phase regulation through eukaryotic evolution.
Summary
Cyclin-dependent kinases (CDKs) play crucial roles in promoting DNA replication and preventing rereplication in eukaryotic cells [1] [2] [3] [4] . In budding yeast, CDKs promote DNA replication by phosphorylating two proteins, Sld2 and Sld3, which generates binding sites for pairs of BRCT repeats (breast cancer gene 1 [BRCA1] C terminal repeats) in the Dpb11 protein [5, 6] . The Sld3-Dpb11-Sld2 complex generated by CDK phosphorylation is required for the assembly and activation of the Cdc45-Mcm2-7-GINS (CMG) replicative helicase. In response to DNA replication stress, the interaction between Sld3 and Dpb11 is blocked by the checkpoint kinase Rad53 [7] , which prevents late origin firing [7, 8] . Here we show that the two key CDK sites in Sld3 are conserved in the human Sld3-related protein Treslin/ticrr and are essential for DNA replication. Moreover, phosphorylation of these two sites mediates interaction with the orthologous pair of BRCT repeats in the human Dpb11 ortholog, TopBP1. Finally, we show that DNA replication stress prevents the interaction between Treslin/ticrr and TopBP1 via the Chk1 checkpoint kinase. Our results indicate that Treslin/ticrr is a genuine ortholog of Sld3 and that the Sld3-Dpb11 interaction has remained a critical nexus of S phase regulation through eukaryotic evolution.
Results and Discussion

CDK-Dependent Interaction between Treslin/Ticrr and TopBP1
Eukaryotic DNA replication initiates from multiple replication origins, which each fire just once per cell cycle. To achieve this, the Mcm2-7 helicase is loaded around double-stranded DNA during G1 phase as an inactive double hexamer [1] . This loading reaction is inhibited by CDK and, therefore, can only occur during G1 phase when CDK activity is low. The helicase is then activated during S phase by formation of the CMG complex, which requires a set of loading factors including Sld2, Sld3, and Dpb11. In budding yeast, this step is promoted by CDK phosphorylation of Sld2 and Sld3. This dual role for CDK ensures that replication origin firing is limited to once per cell cycle [2] .
We were interested in understanding how CDK regulates initiation in mammalian cells and began by identifying binding partners of the breast cancer gene 1 (BRCA1) C terminus (BRCT) repeats in the mammalian ortholog of Dpb11, TopBP1. We found a fragment of a human open reading frame (C15orf42), subsequently identified as Treslin and ticrr [9, 10] , in a two-hybrid screen for TopBP1-interacting proteins. Analysis of the Treslin/ticrr sequence identified a domain conserved across eukaryotic species, the Sld3-Treslin/ticrr domain (STD) [11] . Although the Treslin/ticrr protein is large (1910 aa), the TopBP1-interacting fragment contained amino acid residues 790-1172, which lie downstream of the STD, similar to the position of the essential CDK sites relative to the STD in budding yeast Sld3 ( Figure 1A) . Figure 1B shows that this two-hybrid interaction (growth on -His plates) occurs with a construct containing BRCT repeats 0-5 of TopBP1 as well as a construct containing BRCT0-3. In yeast, CDK phosphorylation of Sld3 generates a binding site for the tandem BRCT repeats 1 and 2 in Dpb11. BRCT1 and 2 of TopBP1 that are contained in the BRCT0-3 construct are orthologous [12] to Dpb11's BRCTs 1 and 2 and are essential for replication [10] , suggesting that BRCT1/2-mediated CDK-dependent Sld3 binding could be conserved. Consistent with this hypothesis, GST-TopBP1-BRCT0/1/2 could bind full-length Treslin/ticrr from cell lysates ( Figure 1C ). Lambda phosphatase treatment of the extract, which caused Treslin/ticrr to migrate slightly faster in sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), eliminated interaction with TopBP1 ( Figure 1C , lanes 1 and 2). Phosphorylation of extract proteins with recombinant cyclinA/Cdk2 caused Treslin/ticrr to migrate more slowly in SDS-PAGE and greatly enhanced interaction with TopBP1 (lanes 3 and 4) (note that interaction with Treslin/ticrr is not evident in lane 3 because of the short exposure time compared to lane 1). This series of experiments suggests a CDK-dependent interaction of Treslin with TopBP1 via BRCT0/1/2. To examine interactions between full-length proteins, we immunoprecipitated TopBP1 from stable cell lines expressing Treslin/ticrr. Figure 1D shows that the anti-TopBP1 antibody did not coimmunoprecipitate Treslin/ticrr from lambda phosphatase-treated extracts but did coimmunoprecipitate Treslin/ticrr after treating extracts with CDK. BRCT0/1/2 of TopBP1 has previously been shown to bind the 9-1-1 complex component Rad9 when phosphorylated at S387 [13] . A phosphorylated synthetic peptide derived from Rad9 (pRad9) was able to bind TopBP1-BRCT0/1/2 and to elute full-length Rad9 from a complex with TopBP1-BRCT0/1/2 (see Figure S1 available online). Figure 1D shows that the phosphorylated Rad9 peptide, but not an unphosphorylated control (Rad9), also eluted Treslin from its complex with TopBP1.
The CDK-dependent interaction was reconstituted with purified cyclinA/Cdk2, GST-TopBP1(0/1/2), and a fragment of Treslin/ticrr containing amino acid residues 790-1172 generated in reticulocyte lysate by in vitro translation ( Figure 1E ). Figure 1E also shows that a fragment comprising amino acid residues 790-1056 but not 1014-1172 interacted with TopBP1 in a CDK-dependent manner.
Identification of Conserved CDK Sites Responsible for Interaction
In parallel with these interaction studies, we sought to identify CDK phosphorylation sites equivalent to Sld3 T600 and S622, which have been conserved in Sld3/Treslin/ticrr family members. Out of 70 potential CDK sites in human Treslin/ticrr (46 sites conserved between humans and mouse; Figure 1A ), we found two sites, T969 and S1001, which were each embedded in short sequence motifs that are conserved among family members (Figure 2A ). These sites are contained within the smallest fragment shown to interact with TopBP1 in Figure 1E . We next tested the relative importance of these two phosphorylation sites. Figure 2B shows that mutation of T969 to alanine in the context of the in vitro-translated Treslin fragment eliminated CDK-induced association with TopBP1-BRCT0/1/2 whereas the S1001-to-alanine mutation resulted in a significant reduction in interaction efficiency. The migration of wild-type and mutant Treslin/ticrr fragments in SDS-PAGE were reduced upon CDK treatment to a similar extent, indicating that phosphorylation of CDK sites outside T969 and S1001 (there are 11 potential CDK sites on the fragment) can occur and contribute to the reduced migration of TopBP1. These phosphorylations, however, do not promote efficient TopBP1 binding, providing an internal control for the specificity of the interaction. To analyze further the sequence requirements for this interaction, we examined the ability of TopBP1 to bind biotinylated synthetic peptides. Figure 2C shows that recombinant TopBP1 (0/1/2) could be pulled down with a Treslin/ticrr peptide containing sequences around T969 when T969 was phosphorylated, but not when T969 was unphosphorylated, showing that phosphorylation of T969, rather than the threonine residue itself, is critical for the interaction. Moreover, mutation of conserved residues at position 21 or 23 relative to T969 (see Figure 2A , asterisks) eliminated TopBP1 binding ( Figure 2C ). Similarly, TopBP1 (0/1/2) bound to a Treslin/ticrr peptide containing sequences around S1001 when S1001 was phosphorylated, but not when it was unphosphorylated. Mutation of conserved residues at 21, 23, and 24 relative to S1001 eliminated binding whereas mutation of the 22 residue reduced binding. We next used fluorescence polarization as a more quantitative approach to measure the affinity of TopBP1 for these peptides. Figure 2D (top panel) shows that the doubly phosphorylated peptide (23PO4) has a higher affinity for TopBP1 (0/1/2) than either singly phosphorylated peptide as the lower K d values (in parentheses) indicate. The pT969 peptide had a higher affinity than the pS1001 peptide, consistent with results in Figure 2B . To examine the roles of the individual BRCT repeats in binding, we used mutants containing single point mutations in the putative phosphopeptide binding site in BRCT1 (B1mut) or BRCT2 (B2mut) or both (B1/2mut) [14] . Figure 2D (top panel) shows that mutation of both BRCTs abolishes binding of the 23PO4 peptide, confirming a canonical phosphorylation-dependent BRCT-phosphopeptide binding event. Mutating BRCT1 alone affected pT969 binding more than mutation of BRCT2 (middle panel), whereas inactivation of BRCT2 had a bigger effect on pS1001 binding than mutation of BRCT1 (bottom panel). These results suggest that pT969 interacts primarily with BRCT1 whereas pS1001 interacts primarily with BRCT2. We note, however, that neither peptide appears to interact exclusively with one or the other BRCT repeat, consistent with the similarity in the primary amino acid sequence surrounding the two critical CDK sites (Figures 2A  and 2C ). Finally, we tested the importance of these phosphorylation sites in the context of the full-length Treslin/ticrr protein. Figure 2E shows that a double alanine substitution of these two phosphorylated residues (T969 and S1001) in the context of the full-length Treslin/ticrr completely prevented interaction with endogenous TopBP1 (as well as with recombinant TopBP1-BRCT0/1/2; Figure S2A ). Thus, these two CDK sites are essential for interaction with TopBP1. (A) Treslin-T969 and S1001 align with Sld3-T600 and S622. A protein computational sequence analysis of TP/SP phosphorylation motifs [30] for the Treslin/ Sld3 family is shown. The alignment was represented using the program Belvu and a color scheme indicating the average BLOSUM62 scores (which are correlated with amino acid conservation) of each alignment column. Red represents average BLOSUM62 scores greater than 3, violet between 3 and 1, and light yellow between 1 and 0.2. Asterisks indicate amino acids mutated for (C). (B) T969 and S1001 are required for CDK-mediated association of Treslin-790-1172 with TopBP1-BRCT0/1/2. In vitro-translated Treslin-790-1172 fragments were pulled down using immobilized GST-TopBP1-BRCT0/1/2 in the presence or absence of exogenous Cdk2. See Figure 1E for legend, except mutant Treslin fragments 969A and 1001A, T969, or S1001 mutated to alanine. (C) Phosphorylation of Treslin-T969 and S1001 creates interaction surfaces for TopBP1-BRCT0/1/2. Recombinant TopBP1-BRCT0/1/2 was pulled down using immobilized biotinylated Treslin peptides. 0/1/2, GST-TopBP1-BRCT0/1/2 (amino acids 1-360); biotinylated peptides: pT969, pS1001, phosphoTreslin-T969, S1001; 21K, 23F, 21A, 22A, 23D, 24D: point mutation of amino acids indicated by asterisks in (A); Coom., Coomassie staining; nonphospho-S1001-peptide was generated by lambda phosphatase treatment of pS1001. (D) Functional TopBP1-BRCT1 and 2 and double phosphorylation of Treslin/ticrr at T969 and S1001 are required for maximal TopBP1-Treslin interaction. A fluorescence polarization analysis using Treslin peptides and TopBP1-BRCT0/1/2 is shown. The following abbreviations are used: dissociation constants in parentheses; TopBP1-BRCT0/1/2 versions (amino acids 1-290): WT, wild-type; B1/2mut, BRCT1 and 2 inactivated (K155E/K250E); B1mut, BRCT1 inactivated (K155E); B2mut, BRCT2 inactivated (K250E). FITC-Treslin peptides: pT969, pS1001, 23PO4, phospho-Treslin-T969, S1001, T969/S1001. (E) Treslin/ticrr interacts with endogenous TopBP1 dependent on T969 and S1001. Interaction of Treslin-WT and 2PM with endogenous TopBP1 was analyzed by coimmunoprecipitation. The following abbreviations are used: WT and 2PM, HeLa-Kyoto cells stably expressing Ac-GFP-Treslin-wild-type or T969A/S1001A; IP, immunoprecipitation; immunoblots: Treslin, anti-GFP; TopBP1, anti-TopBP1. See also Figure S2 .
CDK Sites 969 and 1001 Are Required for DNA Replication
To test the importance of these sites for Treslin function, we developed a small interfering RNA (siRNA) strategy to reduce the levels of endogenous Treslin/ticrr but not siRNA-resistant transgenes. The immunoblot in Figure 3A shows that we could effectively reduce endogenous Treslin/ticrr protein levels by siRNA. Flow cytometry analysis demonstrated that this knockdown (siTr) resulted in almost complete loss of cells capable of incorporating bromodeoxyuridine (BrdU) ( Figure 3B , top row, middle panel) relative to a control siRNA (siCtr; top row, left panel) and also caused a dramatic accumulation of S phase cells ( Figure 3B, bottom panel) . Quantification of cells in different cell-cycle stages revealed that Treslin/ticrr-RNAi cells accumulate primarily in S phase (upper panel, colored bars), consistent with an inhibition of DNA replication and similar to previously published results [9, 10] . We next used stable HeLa-Kyoto cell lines expressing siRNA-resistant transgenes encoding either wild-type (WT) Treslin/ticrr or the double point mutation (2PM), which cannot interact with TopBP1 ( Figure 2E ). Figure 3C shows that both proteins are expressed to similar levels and are resistant to siRNA treatment, in contrast to endogenous Treslin in control cells. Figure 3D shows that expression of the wild-type Treslin/ticrr restored significant BrdU incorporation (dot plots, middle panel) and also greatly reduced the number of cells in S phase (histograms, bottom panel and colored bars) in cells treated with siRNA against Treslin/ticrr. However, the double point mutant did not restore either BrdU incorporation or normal cell-cycle distribution (for more cell lines, see Figure S3 ). The inability of this double alanine substitution mutant to support DNA replication shows that T969 and S1001 are essential for Treslin/ticrr function. This supports the idea that phosphorylation of these residues by CDK is essential to generate a binding site for TopBP1, although we cannot rule out the possibility that the mutations affect some other function of Treslin/ticrr. Additionally, our results do not address the possible function of the remaining 68 CDK sites in Treslin/ticrr. We note that the 2PM mutant migrates very similarly to wild-type protein in SDS-PAGE and migrates faster after lambda phosphatase treatment (Figure S2A) , indicating that at least some of these remaining CDK sites may be phosphorylated in vivo. However, even if these remaining sites are phosphorylated, they cannot promote TopBP1 binding in the absence of T969/S1001 ( Figure 2E ).
Treslin/Ticrr-TopBP1 Interaction Is Inhibited by Chk1
Lastly, we examined Treslin/ticrr and its interaction with TopBP1 after replicative stress. Budding yeast Sld3 is hyperphosphorylated in a Rad53-dependent manner after treatment of cells with hydroxyurea (HU), and this hyperphosphorylation blocks its ability to interact with Dpb11 [7, 8] . As shown in Figure 4A , Treslin does not appear to become hyperphosphorylated after 2 hr treatment with HU. Instead, it migrates faster after HU treatment, similar to the migration of Treslin/ticrr after treatment with lambda phosphatase. However, similar to the situation in budding yeast, Figure 4A shows that the ability of TopBP1-BRCT0/1/2 to interact with Treslin/ticrr is greatly reduced after HU treatment. To determine whether this reduced interaction is dependent upon checkpoints, we pretreated cells with the Chk1 inhibitor AZD7762 30 min before addition of HU treatment. Figure 4A shows that Chk1 inhibition prevents the apparent hypophosphorylation of Treslin/ticrr and also restores its ability to interact with TopBP1. Taken together, these experiments indicate that the DNA damage checkpoint, via Chk1, inhibits the interaction between TopBP1 and Treslin/ticrr.
In addition to its role in promoting replication, CDK inhibits loading of Mcm2-7 into prereplicative complexes (pre-RCs) by directly phosphorylating and inhibiting multiple pre-RC components. However, mutational inactivation of individual CDK phosphorylation sites in budding yeast pre-RC components including ORC, Cdc6, and Mcm2-7 has little or no effect on cell viability or the block to rereplication. Significant levels of rereplication and loss of viability are only seen when CDK regulation of multiple pre-RC components is eliminated [15] . This high degree of redundancy is probably important for the robustness of the block to rereplication [2] but also contributes to the rapid evolution of licensing regulation by CDKs [16] . As a consequence, specific CDK phosphorylation sites involved in this block to rereplication have not been conserved between budding yeast and humans (discussed in [4, 16] ). In contrast, several individual CDK phosphorylation sites in budding yeast Sld2 and Sld3 are either essential or extremely important for cell viability [5, 6, 17] . Consistent with this, our results show that Sld3 phosphorylation sites have been conserved in eukaryotic evolution.
Two lines of evidence suggest, however, that CDK phosphorylation of Sld2 may not be conserved in metazoans. First, T84, the key CDK phosphorylation site in Sld2, is not present in the apparent metazoan ortholog of Sld2, RecQL4 [18] . And second, BRCT4 and 5 in TopBP1, which correspond to BRCT3 and 4 in Dpb11 and are required for phosphopeptide binding to Sld2 in yeast, are dispensable for initiating DNA replication in Xenopus egg extracts [10] . The metazoan TopBP1 has an additional single BRCT repeat (BRCT3) inserted between the Sld3-and Sld2-interacting tandem pairs in Dpb11 [12] , which is essential for DNA replication in Xenopus egg extracts [10] . Determining whether there are additional CDK substrates required for initiating DNA replication in metazoans such as the recently discovered GEMC1 and DUE-B proteins [19, 20] and whether these proteins interact with BRCT3 in TopBP1 will require further work.
The recent crystal structure of the N-terminal region of TopBP1 [14] has confirmed that BRCT repeats 1 and 2 are quite similar to each other and has revealed the presence of a phosphopeptide binding pocket in both repeats. Both Sld3 and Treslin/ticrr contain two phosphorylation sites important for binding. Sequences around the two phosphorylation sites in Treslin/ticrr show significant similarity to each other: there is a conserved acidic residue at position 21 and a conserved hydrophobic residue at position 23, both of which are important for TopBP1 binding to both sites (Figures 2A and 2C) . Indeed, both BRCT repeats appear able to bind to either phosphopeptide ( Figure 2D ), though there is a preference for BRCT1 to bind the T969 peptide and BRCT2 to bind the S1001 peptide. This suggests that the TopBP1-Treslin/ticrr interaction may have evolved from a tandem duplication of both the BRCT repeat in TopBP1 and the phosphopeptide binding site in Treslin/ticrr. However, two phosphorylation sites are not an absolute requirement for functional interaction with TopBP1 because the vertebrate and fission yeast 9-1-1 complex component Rad9 requires just one phosphorylation site for binding BRCT0/1/2 [13] . Moreover, the Arabidopsis thaliana Treslin/ticrr homolog appears to contain just a single conserved CDK site relative to the human and yeast proteins ( Figure S2B ).
Budding yeast Sld3 becomes hyperphosphorylated in response to DNA damage by the checkpoint kinase Rad53 [7, 8] . This phosphorylation blocks the interaction between CDK-phosphorylated Sld3 and Dpb11 [7] . As we have shown here, the interaction between Treslin/ticrr and TopBP1 is also disrupted by the checkpoint pathway in human cells, in this case by Chk1, which is responsible for the intra-S checkpoint in mammalian cells [21] . However, in contrast to the situation in budding yeast, the phosphorylation-dependent shift in SDS-PAGE of Treslin/ticrr is reduced by the Chk1 kinase ( Figure 4B ), suggesting that Chk1 may either prevent the phosphorylation of Treslin/ticrr by CDK or promote its dephosphorylation by an unknown phosphatase. Whether this occurs by direct Chk1 phosphorylation of Treslin/ticrr or by downregulation of S phase CDK activity, perhaps via Cdc25A destabilization [22, 23] , is unknown. In budding yeast, CDK must remain active throughout S phase to prevent the relicensing of origins that have fired. Thus, the intra-S checkpoint cannot operate via CDK inactivation. The presence of CDK-independent mechanisms for preventing rereplication in metazoans, such as the Cdt1 inhibitor, geminin [24] [25] [26] , and the Cdt1 degradation pathway [27] [28] [29] , which operates via a Cul4 ubiquitin ligase, allow the intra-S checkpoint to inhibit CDK without inducing origin relicensing.
Taken together, our results indicate that Treslin/ticrr is a bona fide ortholog of the yeast Sld3 protein and establishes the Sld3-Dpb11 interaction as a critical point of S phase regulation in eukaryotic cells ( Figure 4B ).
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